指南与共识重症综合管理与镇静镇痛心脑血管急症

CURATIVE共识第4部分:优化与监测抗血栓治疗

Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 4-Refining and monitoring antithrombotic therapies.
指南 / 共识 · J Vet Emerg Crit Care (San Antonio) · 2019-01-01
一句话结论CURATIVE共识推荐:犬猫存在血栓风险时,使用华法林或普通肝素应进行治疗监测;阿司匹林或低分子肝素监测证据不足。

该共识针对小动物抗血栓药物(阿司匹林、氯吡格雷、华法林、普通肝素、低分子肝素、利伐沙班)的治疗监测进行系统综述,并按证据等级和质量分类。多数文献来自实验动物模型或健康实验室动物的药代/药效研究,直接回答PICO问题的高级别证据缺乏,限制了推荐强度。最终指南推荐:犬猫存在血栓风险时,使用华法林或普通肝素应进行治疗监测;目前对阿司匹林或低分子肝素进行监测的证据不足以做出强烈推荐。该共识强调该领域存在显著知识空白,需大量额外研究。

要点

  • 犬猫存在血栓风险时,使用华法林或普通肝素应进行治疗监测(CURATIVE共识推荐)。
  • 目前对犬猫使用阿司匹林或低分子肝素进行治疗监测的证据不足,无法做出强烈推荐。
  • 关于抗血栓治疗监测的多数文献来自实验动物模型或健康实验室动物的药代/药效研究。
  • 直接回答PICO问题的高级别证据缺乏,限制了可提供的推荐强度。
  • 该领域存在显著知识空白,需大量额外研究。

适用人群与场景

  • 犬和猫,存在血栓风险,使用抗血栓药物(阿司匹林、氯吡格雷、华法林、普通肝素、低分子肝素、利伐沙班)进行治疗监测的场景。

处置流程与药物剂量

  • 犬猫存在血栓风险时,使用华法林或普通肝素应进行治疗监测(CURATIVE共识推荐)。
  • 目前对犬猫使用阿司匹林或低分子肝素进行治疗监测的证据不足,无法做出强烈推荐。

研究设计与关键结果

  • 该共识通过系统文献综述和Delphi式调查制定指南;PICO问题涉及6种抗血栓药物或药物类别(阿司匹林、氯吡格雷、华法林、普通肝素、低分子肝素、利伐沙班)的治疗监测效用。
  • 多数关于抗血栓药物监测的文献来自实验动物疾病模型或健康实验室动物的药代动力学和药效学研究。
  • 直接回答PICO问题的高级别证据缺乏,限制了可提供的推荐强度。

证据类型、等级与局限

  • 证据类型:指南(CURATIVE共识),基于系统文献综述(按证据等级和质量分类)和Delphi式调查。
  • 局限:直接回答PICO问题的高级别证据缺乏,限制了推荐强度;多数文献来自实验动物模型或健康实验室动物的药代/药效研究;该领域存在显著知识空白,需大量额外研究。

对床旁实践的改变

  • 对犬猫使用华法林或普通肝素且存在血栓风险时,应进行治疗监测(CURATIVE共识推荐)。
  • 对犬猫使用阿司匹林或低分子肝素时,目前证据不足以强烈推荐进行治疗监测(CURATIVE共识)。

指南或共识出处

  • CURATIVE共识:小动物抗血栓药物合理使用共识(Journal of Veterinary Emergency and Critical Care),第4部分:优化与监测抗血栓治疗。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: To systematically review the evidence for therapeutic monitoring of antithrombotic drugs in small animals, develop guidelines regarding antithrombotic monitoring, and identify knowledge gaps in the field.

DESIGN: First, a standardized, systematic literature review was conducted to address predefined PICO (Population/Patient, Intervention, Control, Outcome) questions, with categorization of relevant articles according to level of evidence and quality. Preliminary guidelines were developed by PICO worksheet authors and the domain chair. Thereafter, a Delphi-style survey was used to develop consensus on guidelines regarding therapeutic monitoring of antithrombotics in dogs and cats.

SETTING: Academic and referral veterinary medical centers.

RESULTS: PICO questions regarding the utility of therapeutic monitoring were developed for 6 different antithrombotic drugs or drug classes, including aspirin, clopidogrel, warfarin, unfractionated heparin, the low molecular weight heparins, and rivaroxaban, The majority of the literature pertaining to therapeutic monitoring of antithrombotic drugs was either performed in experimental animal models of disease or involved studies of drug pharmacokinetics and pharmacodynamics in healthy laboratory animals. There was a paucity of high level of evidence studies directly addressing the PICO questions, which limited the strength of recommendations that could be provided. The final guidelines recommend that therapeutic monitoring should be performed when using warfarin or unfractionated heparin in dogs and cats at risk of thrombosis. There is insufficient evidence to make strong recommendations for therapeutic monitoring of aspirin or low molecular weight heparin in dogs and cats at this time.

CONCLUSIONS: As in other CURATIVE domains, significant knowledge gaps were highlighted, indicating the need for substantial additional research in this field. Ongoing investigation of the role of therapeutic monitoring of antithrombotic therapies will undoubtedly facilitate improved outcomes for dogs and cats at risk of thrombosis.

来源:J Vet Emerg Crit Care (San Antonio),查看原文。版权归原作者所有。

参考来源

  1. Sharp CR, deLaforcade AM, Koenigshof AM, et al. Consensus on the Rational Use of Antithrombotics in Veterinary Critical Care (CURATIVE): Domain 4-Refining and monitoring antithrombotic therapies. J Vet Emerg Crit Care (San Antonio). 2019. PMID: 30654420. doi:10.1111/vec.12794

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。